2021
DOI: 10.1016/j.isci.2021.102261
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

Abstract: Construction of tumor microenvironment responsive probe with more than one imaging modality, in particular toward hypoxia of solid tumors, is an appealing yet significantly challenging task. In this work, we designed a hypoxia-activated probe TBTO (Triphenylamine-Benzothiadiazole-Triphenylamine derivative featuring four diethylamino N-Oxide groups) for in vivo imaging. TBTO could undergo bioreduction in a hypoxic microenvironment to yield compound TBT sharing both near-infrared (NIR) aggregation-induced emissi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 50 publications
0
31
0
Order By: Relevance
“…Several design strategies have been employed to develop PA probes to visualize tumor hypoxia. 183,208,310–323…”
Section: Activatable Pa Probesmentioning
confidence: 99%
“…Several design strategies have been employed to develop PA probes to visualize tumor hypoxia. 183,208,310–323…”
Section: Activatable Pa Probesmentioning
confidence: 99%
“…Li and his co-workers rationally synthesized a hypoxia-activable probe TBTO which could undergo bioreduction in a hypoxic microenvironment and be converted to an AIE-active product TBT. In vitro and in vivo assessments revealed the FI/PAI ability of TBT ( Figure 12 ) ( Li M. et al, 2021 ). Additionally, Liu et al designed two new AIEgens DPMD and TPMD with a cross-shaped D-A structure.…”
Section: Bimodal Imaging Of Tumor Based On Near-infrared-i Fluorescencementioning
confidence: 99%
“…(E) In vivo PA images of the tumor site in the mice after tail intravenous injection with TBTO NPs (200 μl, 1 mg/ml) or saline (200 μl) as the control. Reproduced with permission from Li M. et al (2021) . Copyright 2021, Cell Press.…”
Section: Bimodal Imaging Of Tumor Based On Near-infrared-i Fluorescencementioning
confidence: 99%
“…[ 68 ] Figure listed some typical AIE PTAs. [ 41,66–73 ] It should be emphasized that if the energy of excited electrons is decayed by the nonradiative pathway, the fluorescence of the PTAs which is induced by radiative energy decay should be relatively weak. Therefore, the AIE PTAs with strong photothermal conversion efficiency are always accompanied by weak fluorescence.…”
Section: The Overview Of Aiementioning
confidence: 99%